<ѻý>Hospitalizations After Fake Ozempic; Abortion Rights Win Big; Ketamine Use Boomsѻý> Health news and commentary from around the Web gathered by ѻý staff Nov 08, 2023
<ѻý>Kidney Week Roundup: Cell Therapy Cuts Immunosuppressive Drug Use Post-Transplantѻý> Plus: bardoxolone methyl for diabetic kidney disease and spironolactone in hemodialysis patients Nov 07, 2023
<ѻý>Tone Matters in Weight-Loss Talks; Salt and Diabetes; Nix Brominated Veg Oil?ѻý> News and commentary from the endocrinology world Nov 07, 2023
<ѻý>Novel Aldosterone Synthase Inhibitor Cuts Albuminuria in Phase II Trialѻý> Trial tested BI 690517 with and without empagliflozin Nov 06, 2023
<ѻý>Gene Therapy Controls Diabetic Eye Disease for at Least a Yearѻý> All but one patient with nonproliferative diabetic retinopathy had stable disease or improvement Nov 06, 2023
<ѻý>Eye Drops Make Bid for Role in Diabetic Macular Edemaѻý> Improved visual acuity, retinal thickness at 6 and 12 weeks, but treatment burden questioned Nov 05, 2023
<ѻý>ERA and SGLT2 Inhibitor Combo Cuts Albuminuria in Chronic Kidney Diseaseѻý> But ZENITH-CKD trial had to pivot to only using low-dose zibotentan due to fluid retention Nov 05, 2023
<ѻý>Heat and Cardiovascular Death; Time-Restricted Eating or Caloric Restriction in T2Dѻý> Also in TTHealthWatch: managing nasal airway obstruction Nov 04, 2023 podcast
<ѻý>Year in Review: Type 2 Diabetesѻý> New approvals, guidance on GLP-1s before surgery, and access issues led the news in 2023 Nov 01, 2023
<ѻý>Intermittent Fasting for T2D; Omnipod 5 App Cleared; GLP-1 Meds and Thyroid Cancerѻý> News and commentary from the endocrinology world Oct 31, 2023
<ѻý>Wegovy and Thyroid Cancer; Maine Shooter's Mental Health; 469 Heat Deathsѻý> Health news and commentary from around the Web gathered by ѻý staff Oct 30, 2023
<ѻý>Diabetic Eye Screening: Reducing Frequency May Raise Retinal Risksѻý> Switching from annual to biennial exams would delay diabetic retinopathy diagnoses, study shows Oct 27, 2023
<ѻý>Another Study Highlights Metformin's Dementia Protection Propertiesѻý> Association appeared irrespective of HbA1c level Oct 25, 2023
<ѻý>Hospitalizations With Fake Ozempic; Vosoritide OK'd for All Ages; Mounjaro for Kids?ѻý> News and commentary from the endocrinology world Oct 24, 2023
<ѻý>Counterfeit Ozempic; Mary Lou Retton Discharged; No Such Thing as Free Will?ѻý> Health news and commentary from around the Web gathered by ѻý staff Oct 24, 2023
<ѻý>CVS Pulls Phenylephrine Cold Meds; Doc's Murder/Suicide; Red Meat and Diabetesѻý> Health news and commentary from around the Web gathered by ѻý staff Oct 20, 2023
<ѻý>Highly Potent Statin Stands Out for Diabetes, Cataract Risksѻý> Head-to-head comparison of rosuvastatin vs atorvastatin in LODESTAR trial Oct 19, 2023
<ѻý>Gestational Diabetes Exposure in Utero Linked to Brain Changes in Kidsѻý> These changes may contribute to an increased risk of obesity in kids, researcher says Oct 18, 2023
<ѻý>Tirzepatide Has Huge Impact on Weight, Even After Loss From Lifestyle Changeѻý> Trial participants lost over a fifth of their body weight atop diet, exercise-induced losses Oct 16, 2023
<ѻý>Farxiga Cuts A1c in Pediatric Diabetes; Late-Stage CAH Win; At-Home Menopause Testѻý> News and commentary from the endocrinology world Oct 10, 2023
<ѻý>Time to Recognize Cardiovascular-Kidney-Metabolic Syndrome, AHA Saysѻý> Pooled cohort equations will make way for new CKM risk calculator Oct 09, 2023
<ѻý>Inflammation of the Aorta; Afib in the Hospitalѻý> Also in TTHealthWatch: standards for osteoporosis screening and HbA1c in premenopausal women Oct 07, 2023 podcast
<ѻý>CPAP Turns in Mixed Results for Patients With Diabetic Eye Diseaseѻý> Slower progression of retinal disease, but an increase in microhemorrhages Oct 06, 2023
<ѻý>Smoking-Related Metabolic Changes Partly Drive Type 2 Diabetes Riskѻý> Those with the most metabolic changes, genetic risk had a threefold higher diabetes risk Oct 06, 2023
<ѻý>Faster-Acting Insulin Aspart Safe for Pregnant Women With Diabetesѻý> The faster formulation led to fewer hypoglycemia events versus conventional insulin aspart Oct 06, 2023
<ѻý>Mixed Bag for Early Metformin in Gestational Diabetesѻý> EMERGE trial misses on primary endpoint, but secondary outcomes suggest potential benefit Oct 03, 2023
<ѻý>Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2Dѻý> Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
<ѻý>Pharmacists Improve Diabetes Control for Hispanic Patientsѻý> Medication-adjustment recommendations were linked to some improvements in type 2 diabetes Oct 02, 2023
<ѻý>MedPod Today: Big Medical Bill; GLP-1 Agonist Plateau; Grateful Patient Fundraisingѻý> ѻý reporters offer further insights on these recently covered topics Sep 29, 2023 podcast
<ѻý>New Insight Into Hyperglycemia Risk With PI3K Inhibitor for Breast Cancerѻý> Significantly more common in community setting, predicted by high baseline HbA1c Sep 28, 2023
<ѻý>FDA Adds Intestinal Blockage Reports to Ozempic Labelingѻý> Joins other approved GLP-1 receptor agonists in noting the potential adverse reaction Sep 28, 2023
<ѻý>Postmenopausal Fracture Risk for SGLT2 Inhibitors Similar to Other Diabetes Drugsѻý> Lower risk compared with DPP-4 inhibitors, and similar risk versus GLP-1 receptor agonists Sep 26, 2023
<ѻý>Record-Breaking Obesity Certifications; 365-Day CGM Data; Med Spa Mounjaro Lawsuitsѻý> News and commentary from the endocrinology world Sep 26, 2023
<ѻý>AI System Outperforms Standard Review of Imaging for Retinal Diseaseѻý> Offers potential to reduce current manual grading workload Sep 25, 2023
<ѻý>The GLP-1 Agonist Plateau No One's Talking Aboutѻý> Weight stabilization is no surprise to specialists, but for patients it's more complicated Sep 22, 2023
<ѻý>FDA Approves Another SGLT2 Inhibitor for Treating CKDѻý> Empagliflozin adds indication in adults, regardless of diabetes status Sep 22, 2023
<ѻý>FDA Panel: All Thumbs Down for GLP-1 Agonist Implant for Diabetesѻý> We haven't seen "the best version of this device," said panel member Sep 22, 2023
<ѻý>Third Time's a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise.ѻý> Advisory committee to weigh in on safety concerns with GLP-1 receptor agonist implant Sep 20, 2023
<ѻý>Diabetes in Night Owls; 'Paradigm-Shifting' Drugs; Transgender Trials Unethical?ѻý> News and commentary from the endocrinology world Sep 19, 2023
<ѻý>Direct-to-Consumer Lab Tests Raise Ethical Questions, Researchers Sayѻý> Privacy policies, terms of sale often are unclear Sep 18, 2023